New Wave Biotech and iMEAN have partnered to offer biomanufacturers a pioneering combined solution for end-to-end bioprocess optimisation, combining New Wave’s downstream process, TEA and LCA modelling capabilities with iMEAN’s strain design and upstream process modelling expertise. The EU Biotech Act, US BIOSECURE Act and China’s Five-Year Plan are all accelerating demand for sovereign biomanufacturing […]
